Novo Nordisk, the world’s biggest insulin maker, has for years kept away from the acquisition strategy of Sanofi, Pfizer Inc. and other drugmakers, preferring to focus on internal research and development. That tack has paid off for Novo, the best-performing…

According to Factset, the bulk of S&P 500 companies have reported earnings. To this date, the blended earnings decline is about 1%. http://www.factset.com/websitefiles/PDFs/earningsinsight/earningsinsight_8.6.15 The last quarterly earnings decline noted by the S&P 500 companies was Q3, 2012. As then, bears…